Profile
PTPI ZTS HLN TAK TEVA ITCI
Company Name Petros Pharmaceuticals, Inc. Zoetis Inc. Haleon plc Takeda Pharmaceutical Company Limited Teva Pharmaceutical Industries Limited Intra-Cellular Therapies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $533.05K $70.23B $48.53B $47.75B $20.17B $14.05B
Employees 0.02K 13.80K 24.56K 49.28K 33.89K 0.86K
CEO Mr. Fady Boctor M.B.A. Ms. Kristin C. Peck Mr. Brian James McNamara Mr. Christophe Weber Mr. Richard D. Francis Dr. Sharon Mates Ph.D.
Ratings
PTPI ZTS HLN TAK TEVA ITCI
Quant Rating Score 2 3 3 3 1 1
Quant Rating Sell Neutral Neutral Neutral Strong Sell Strong Sell
Trading
PTPI ZTS HLN TAK TEVA ITCI
Last Close $0.1478 $155.99 $10.76 $15.06 $17.6 $131.87
High 52 $0.65 $196.48 $10.77 $15.37 $22.77 $131.91
Low 52 $0.01 $144.45 $8.19 $12.6 $12.82 $64.96
Price vs. 52 Week High -77.26 % -20.61 % -0.09 % -2.02 % -22.71 % -0.03 %
Price vs. 52 Week Low 1378 % 7.99 % 31.38 % 19.52 % 37.29 % 103 %
Total Return
PTPI ZTS HLN TAK TEVA ITCI
1 Month Return 169.22 % 7.99 % 15.08 % 7.11 % 29.51 % 0 %
3 Month Return -43.15 % -9.01 % 12.67 % 11.31 % 4.45 % 3.83 %
6 Month Return -53.52 % -11.78 % 11.97 % 9.29 % 2.86 % 44.45 %
9 Month Return -54.37 % -17.16 % 11.85 % 8.58 % 2.56 % 77.2 %
YTD Return -62.48 % -4.26 % 12.79 % 13.75 % -20.15 % 57.89 %
1 Year Return -77.09 % -5.41 % 31.38 % 15.31 % 11.82 % 96.82 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
PTPI ZTS HLN TAK TEVA ITCI
Dividend Yield Percentage (TTM) - 1.18 % 0.02 % 4.58 % - -
Dividend Paid and Capex Coverage Ration (TTM) -0 % 2.05 % - 1.76 % 2.5 % -227.26 %
Dividend Per Share (TTM) - 1.86 % 0.07 % 196 % - -
Payout Ratio (TTM) -2978.34 % 31.62 % - 145.09 % - -
Growth
PTPI ZTS HLN TAK TEVA ITCI
Asset Growth 31369.33 % 8.25 % -9.55 % 87.69 %
Gross Profit Growth -6.96 % 1.76 % 5.47 % 44.88 %
Revenue Growth -12.2 % 5.87 % 4.4 % 46.62 %
Revenue 3 Year -91.12 % 33.13 % 1.52 % 556.51 %
Revenue 5 Year -98.99 % 103.83 % -5.5 % 600974.32 %
Revenue 10 Year -99.55 % 152.69 % -38.45 % 32663.23 %
EBIT Growth -80.38 % -64.98 % -169.63 % 26.77 %
Net Income Growth -75.41 % -54.56 % -193.2 % 46.54 %
Net Income 3 Yeari Growth Per Share 79.23 % -61.74 % -482.97 % 79.29 %
Net Income 5 Yeari Growth Per Share 98.65 % 32.36 % -58.26 % 72.95 %
Net Income 10 Yeari Growth Per Share 99.45 % 35.42 % -140.46 % 32.41 %
Operating Income Growth -129731.66 % -56.36 % -169.98 % 26.77 %
Operating Cash Flow Growth (CFG) 65.87 % -26.69 % -8.85 % 41.08 %
Operating 3 Year CFG 97.02 % -29.25 % 52.26 % 77.79 %
Operating 5 Year CFG -103.15 % 118.64 % 123.59 % 69.4 %
Operating 10 Year CFG -100.4 % 384.17 % -81.66 % 10.87 %
EPS Growth 99.64 % -54.92 % -190 % 50.68 %
EPS Diluted Growth 99.64 % -54.86 % -190 % 50.68 %
Book Value Per Share 13529.62 % 13.54 % -30.36 % 80.54 %
Share Holder 3 Year Equity Growth Per Share -2950.49 % 40.38 % -49 % 116.52 %
Share Holder 5 Year Equity Growth Per Share -2954.22 % 41.33 % -62.86 % 215.14 %
Share Holder 10 Year Equity Growth Per Share -5433.98 % 195.14 % -82.6 % 164.65 %
Dividend Per Share Growth - 1.95 % - -
Dividend 3 Year Growth Per Share - 1.19 % - -
Dividend 5 Year Growth Per Share - 101.42 % -100 % -
Dividend 10 Year Growth Per Share - 102.58 % -100 % -
Debt Growth -10.76 % 10.53 % -10.29 % 0.25 %
Free Cash Flow Growth -34031.53 % -31.4 % -11.05 % 40.95 %
Updated On 31 Dec 2024 31 Mar 2024 31 Dec 2024 31 Dec 2024
Profitability
PTPI ZTS HLN TAK TEVA ITCI
Gross Profit Margin TTM 76.28 % 69.85 % 61.52 % 54.74 % 48.74 % 91.63 %
Return on Assets TTM -189.77 % 17.46 % 4.2 % 1.38 % -4.17 % -5.46 %
Return on Equity TTM -552.12 % 49.65 % 8.73 % 2.83 % -26.15 % -7.4 %
Return on Capital Employed TTM 239.16 % 31.33 % 7.74 % 3.62 % -1.14 % -10.05 %
Net Income Per EBT TTM 140.96 % 79.35 % 75.5 % 89.75 % 127.75 % 100.64 %
EBT Per Ebit TTM 80.99 % 92.36 % 86.58 % 49.18 % 423.43 % 63.57 %
EBIT Per Revenue TTM -345.84 % 36.65 % 19.64 % 10.3 % -1.83 % -17.15 %
Cash Flow To Debt Ratio TTM -35.24 % 43.79 % - 22.2 % 6.9 % -430.93 %
Receivables Turnover TTM 12.29 7.03 5.9 6.23 5.41 4.09
Payables Turnover TTM 0.52 6.45 2.19 4.5 3.85 2.18
Inventory Turnover TTM 0.9 1.21 3.63 1.66 2.82 2.17
Fixed Asset Turnover TTM 3740.21 % 256.4 % 584.75 % 226.93 % 334.34 % 4569.25 %
Asset Turnover TTM 48.07 % 65.01 % 32.73 % 30.31 % 42.07 % 49.79 %
Operating Cash Flow Per Share TTM -0.03 6.55 - 677.91 1.1 -0.71
Free Cash Flow Per Share TTM -0.03 5.1 - 483.45 0.66 -0.71
Cash Per Share TTM 4.62 % 440.62 % 24.05 % 33229.49 % 291.26 % 970.67 %
Operating Cash Flow Sales Ratio TTM -50.92 % 31.9 % - 23.47 % 7.54 % -10.75 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.94 % 77.82 % - 71.32 % 60.06 % 100.44 %
Cash Flow Coverage Ratios TTM -35.24 % 43.79 % - 22.2 % 6.9 % -430.93 %
Price To Free Cash Flows Ratio TTM -0.2 30.56 - 8.85 26.68 -191.12
Price To Operating Cash Flows Ratio TTM -7.68 24.02 - 6.31 15.85 -185.85
Price Cash Flow Ratio TTM -7.68 24.02 - 6.31 15.85 -185.85
Income Statement (TTM)
PTPI ZTS HLN TAK TEVA ITCI
Revenue $0.01B $9.26B $11.23B $4263.76B $16.54B $0.68B
Gross Profit $0B $6.54B $6.95B $2832.26B $8.06B $0.62B
Gross Profit Ratio 76.28% 70.62% 61.85% 66.43% 48.74% 91.63%
EBITDA $-0.01B $3.87B $2.51B $874.6B $0.72B $-0.12B
Net Income $-0.01B $2.49B $1.44B $144.07B $-1.64B $-0.07B
EPS Diluted -0.02 5.47 0.32 45.58 -1.45 -0.72
Balance Sheet (MRQ)
PTPI ZTS HLN TAK TEVA ITCI
Long Term Debt $0B $5.39B $8.54B $5029.93B $16B $0.01B
Total Liabilities $0.02B $9.47B $18.09B $7834.79B $33.61B $0.22B
Total Equity $-7.47B $4.77B $16.22B $7274.01B $5.73B $1.15B
Total Investments $3.71B $0B $0.08B $445.7B $0B $0.69B
Total Debt $0.01B $6.74B $10.1B $4843.75B $18.08B $0.02B
Total Assets $0.01B $14.24B $34.32B $15108.79B $39.33B $1.37B
Cash Flow Statement (TTM)
PTPI ZTS HLN TAK TEVA ITCI
Net Income $-0.01B $2.5B $1.44B $144.07B $-1.96B $-0.07B
Inventory $0B $-0.04B $0.22B $-115.74B $0.17B $-0.01B
Dividends Paid $-1.29B $-0.79B $-0.57B $-287.19B $0B $0B
Operating Cash Flow $-0B $2.95B $2.3B $716.34B $1.25B $-0.07B
Capital Expenditure $-0B $-0.66B $-0.25B $-480.73B $-0.5B $-0B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 4.745
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 1.2033
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 9.35
ALVOW Alvotech 1.45
AMPH Amphastar Pharmaceuticals, Inc. 24.665
AMRX Amneal Pharmaceuticals, Inc. 7.455
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 71.665
AQST Aquestive Therapeutics, Inc. 2.76
ASRT Assertio Holdings, Inc. 0.6382
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 9.375
AYTU Aytu BioPharma, Inc. 1.28
ETFs With Exposure to PTPI
Ticker ETF Name Weight Percentage Price
VXF Vanguard Extended Market Index Fund 0 177.365
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 132.11
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 132.12
VEMPX Vanguard Extended Market Index InstlPlus 0 326.02
Unlock